drugset / Trial / NCT02836652
Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients Without Antiplatelet Therapy
RandomizedParallel-groupTriple-blindTreatment
Summary
This study is a prospective, multi-center, randomized, double-blind placebo-controlled study of subjects receiving the HM II LVAD as per the current FDA approved indications for use.
Timeline
- Start
- 2016-11
- Primary completion
- 2019-02-21
- Completion
- 2019-07-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aspirin | Small molecule | 81 mg | — |
| Background | Warfarin | Small molecule | — | — |